Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.

Clinical genitourinary cancer - 1 Jun 2024

Brown Landon C, Robinson Myra, McCormack Michael, Steuerwald Nury, Symanowski James, Sha Wei, Bose Rupali, Neelands Brittany, Akinyelu Tobi, Livasy Chad, Li Wencheng, Haynes Nathanael, Hamilton Alicia, Smith Mathew, Clark Peter E, Patel Jai, Burgess Earle F

Abstract excerpt

INTRODUCTION: Men with advanced germ cell tumors (GCT) treated with chemotherapy are at high risk of venous thromboembolism (VTE). Predictors of VTE may identify patients who would benefit from prophylactic anticoagulation. PATIENTS AND METHODS: Men with advanced GCT (Stage IS, II, III) treated with chemotherapy were identified at 2 centers. High genomic risk was defined from a 5 single nucleotide polymorphism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Germ Cell and Embryonal

Share to Risk Factors

Share to Testicular Neoplasms

Share to Thrombophilia

Share to Venous Thromboembolism

Share to Young Adult

Source

Identifiers

PMID: 38697880
DOI: 10.1016/j.clgc.2024.102086

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.PMID 38697880Read ↗

Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort studySemantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.Semantic proximity Read ↗

[The genetics of thrombosis in cancer].Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.Semantic proximity Read ↗

Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocolSemantic proximity Read ↗

Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid TumorsSemantic proximity Read ↗

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.